| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10917752 | Radiotherapy and Oncology | 2016 | 6 Pages |
Abstract
Salvage HDR BT is a promising treatment option for patients with localized relapse of previously irradiated prostate cancer. Lower PSA nadir after primary radiotherapy and longer primary disease-free interval influence the outcome.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Piotr Wojcieszek, Marta Szlag, Grzegorz GÅowacki, Agnieszka Cholewka, Marzena Gawkowska-SuwiÅska, Sylwia Kellas-ÅlÄczka, Brygida BiaÅas, Marek FijaÅkowski,